CARLSBAD, Calif.–(BUSINESS WIRE)–Arima Genomics, Inc., a cancer diagnostics company bringing DNA sequence and structure together to advance cancer diagnosis and therapy selection, today announced its participation in the Association for Molecular Pathology (AMP) 2026 Annual Meeting & Expo, November 10–14 in Seattle. Three scientific presentations and a corporate workshop will highlight applications of Arima Hi-C technology across solid tumors and lymphoma. The meeting will also feature an
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
